| View |
|
DRP-5834-07
|
Ceftriaxone (as sodium)
|
Jazeft
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Kyung Dong Pharm Co., Ltd
|
Korea
|
CLIDP Conversion
|
26 February 2024
|
12 September 2028
|
| View |
|
DRP-5830-05
|
Pantoprazole
|
Centramed
|
40 mg
|
Capsule
|
Proton Pump Inhibitor
|
Interphil Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
26 February 2024
|
09 June 2029
|
| View |
|
DRP-586-02
|
Domperidone
|
Gastromec
|
10 mg
|
Tablet
|
Gastrokinetic ( Prokinetic)
|
Micro Labs Limited
|
India
|
CLIDP Conversion
|
19 February 2024
|
17 October 2029
|
| View |
|
DRP-6261-04
|
Pantoprazole (as sodium sesquihydrate)
|
Pantodyme
|
40 mg
|
Lyophilized Powder for Injection (I.V.)
|
Proton Pump Inhibitor
|
Opsonin Pharma Limited
|
Bangladesh
|
CLIDP Conversion
|
03 March 2024
|
09 February 2025
|
| View |
|
DRP-6066-03
|
Pantoprazole (as sodium)
|
Pantostan
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
United Biotech Pvt. Ltd
|
India
|
CLIDP Conversion
|
06 March 2024
|
28 January 2026
|
| View |
|
DRP-5966-25
|
Co-Amoxiclav
|
Kiddymox
|
457 mg/ 5 mL
|
Powder for Suspension
|
Antibacterial
|
Giyaan Pharma Private Limited
|
India
|
Renewal
|
31 May 2024
|
27 January 2030
|
| View |
|
DRP-5915-04
|
Ofloxacin + Dexamethasone
|
Oflaz-DM
|
0.3 % w/v / 0.1% w/v
|
Ophthalmic Solution
|
Antibacterial
|
Indiana Ophthalmics LLP
|
India
|
Renewal
|
20 March 2024
|
23 December 2029
|
| View |
|
DRP-6949-05
|
Omeprazole
|
Ulcerate
|
20 mg
|
Delayed Release Capsule
|
Proton Pump Inhibitor
|
Kopran Limited
|
India
|
CLIDP Conversion
|
05 February 2024
|
14 December 2026
|
| View |
|
DRP-6758-18
|
Paracetamol + Vitamin B-Complex
|
Nervcureplus
|
00 mg/50 mg/100 mg/100 mcg
|
Film-Coated Tablet
|
Analgesic/ Antipyretic/ Vitamin
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
21 February 2024
|
18 February 2029
|
| View |
|
DRP-6569-03
|
Isotretinoin
|
Akniblaz
|
10 mg
|
Softgel Capsule
|
Anti-acne
|
Phil Inter Pharma Co., Ltd. (Plant 1)
|
Vietnam
|
CLIDP Conversion
|
19 February 2024
|
15 November 2028
|
| View |
|
DRP-6561-02
|
Pantoprazole (as Sodium)
|
Amphoter IV
|
40 mg
|
Powder for Solution for Injection (IV)
|
Proton Pump Inhibitor
|
Umedica Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
15 February 2024
|
04 March 2026
|
| View |
|
DRP-6556-06
|
Nystatin
|
Nystasave
|
100,000 Units/mL
|
Oral Suspension
|
Antifungal
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
20 January 2024
|
07 March 2026
|
| View |
|
DRP-7196-02
|
Olanzapine
|
OlaKip
|
10 mg
|
Tablet
|
Atypical Antipsychotic
|
Micro Labs Limited
|
India
|
CLIDP Conversion
|
27 February 2024
|
27 June 2027
|
| View |
|
DRP-7128-06
|
Sitagliptin (as phosphate monohydrate)
|
None
|
100 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
01 February 2024
|
20 April 2026
|
| View |
|
DRP-7127-05
|
Sitagliptin (as phosphate monohydrate)
|
None
|
25 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase-4 Inhibitor
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
01 February 2024
|
20 April 2026
|
| View |
|
DRP-708-05
|
Salbutamol (as sulfate) + Guaifenesin
|
Vento-Aid Plus
|
1 mg/50 mg per 5 mL
|
Syrup
|
Bronchodilator / Expectorant
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
15 February 2024
|
15 January 2029
|
| View |
|
DRP-7074-13
|
Meropenem (as trihydrate)
|
Merodime
|
1 g
|
Powder for Injection (IV)
|
Antibacterial
|
Daffodills Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
06 February 2024
|
06 March 2027
|
| View |
|
DRP-7656-01
|
Clozapine
|
Clozakip
|
100 mg
|
Tablet
|
Antipsychotic
|
Micro Labs Limited
|
India
|
CLIDP Conversion
|
19 February 2024
|
30 June 2028
|
| View |
|
DRP-7568-04
|
Cefuroxime (as Axetil)
|
Cefuxal
|
500 mg
|
Film-Coated Tablet
|
Antibacterials (Cephalosporins)
|
J.M. TOLMANN LABORATORIES INC.
|
Philippines
|
CLIDP Conversion
|
25 January 2024
|
24 February 2029
|
| View |
|
DRP-7470-06
|
Alpha Ketoanalogues + Essential Amino Acids
|
Ketonep
|
|
Film-Coated Tablet
|
Renal Nutritional Therapy
|
Pharose Remedies Ltd
|
India
|
CLIDP Conversion
|
01 March 2024
|
01 February 2029
|